Literature DB >> 6874824

Analysis of acenocoumarin and its amino and acetamido metabolites in body fluids by high-performance liquid chromatography.

H H Thijssen, L G Baars, M J Reijnders.   

Abstract

Acenocoumarin and its acetamido metabolite, after extraction at pH 4.4, were analysed by isocratic reversed-phase high-performance liquid chromatography using aqueous acetonitrile (pH 4.90) as eluent. Warfarin was used as internal standard. The amino metabolite, after back-extraction into 0.5 N HCl, was derivatized by diazotization and heat treatment. The resulting product was analysed by the same reversed-phase system. The sensitivity of the method for acenocoumarin and its amino metabolite was in the range of 20 ng/ml. To achieve this sensitivity for the analysis of the acetamido compound, the acetonitrile content of the eluent had to be lowered. The assay was applied to the analysis of plasma samples of patients under acenocoumarin therapy. The disposition of the amino compound in rats was investigated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874824     DOI: 10.1016/s0378-4347(00)84426-6

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Pharmacokinetic analysis of a new acenocoumarol tablet formulation during a bioequivalence study.

Authors:  J Popović; M Mikov; V Jakovljević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Apr-Jun       Impact factor: 2.441

3.  Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?

Authors:  H H Thijssen; L G Baars
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

4.  Pharmacokinetic drug-drug interaction of the novel anticancer agent E7070 and acenocoumarol.

Authors:  H J G Desirée van den Bongard; Rolf W Sparidans; David J P Critchley; Jos H Beijnen; Jan H M Schellens
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

5.  The role of the intestinal microflora in the reductive metabolism of acenocoumarol in man.

Authors:  H H Thijssen; L G Baars; M J Hazen; A E Van den Bogaard
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.